Clinical Trial Update: A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 trial of simeprevir and sofosbuvir for HIV/Hepatitis C was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Simeprevir (simeprevir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: University of California, San Francisco | Conditions: Hepatitis C, Chronic, HIV CDC Category A1 | Phase 4 | Status: WITHDRAWN